EnGeneIC Ltd — Form D
EnGeneIC Ltd of NEW SOUTH WALES, C3, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-29. The offering totals $6.0M, of which $2.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-07-29
- Form: D
- Accession: 0000897069-15-000417
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $2.9M
- Remaining: $3.1M
- Investors: 5
- Date of first sale: 2015-03-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-244678
Issuer
- Name: EnGeneIC Ltd
- CIK: 0001648902
- Entity type: Other
- Jurisdiction: BERMUDA
- Incorporated: 2015
- Address: BUILDING 2, NEW SOUTH WALES, C3, 2066
- Phone: (917) 471-0710
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| William Louis Delaat | Director | New South Wales, C3 |
| Mervyn John Turner | Director | New South Wales, C3 |
| Stuart Wardman-Browne | Director | Sidney, C3 |
| Richard Woods | Director | Lebanon, NH |
| Mervyn Turner | Director | Los Angeles, CA |
| Edward Miller | Director | Wellfleet, MA |
| Yvonne Perlberg | Director | New South Wales, C3 |
| David Seaton | Executive Officer | New South Wales, C3 |
| Himanshu Brahmbhatt | Director | New South Wales, C3 |
| Himanshu Brahmbhatt | Executive Officer | New South Wales, C3 |
| Himanshu Brahmbhatt | Promoter | New South Wales, C3 |
| Jennifer MacDiarmid | Director | New South Wales, C3 |
| Jennifer MacDiarmid | Executive Officer | New South Wales, C3 |
| Jennifer MacDiarmid | Promoter | New South Wales, C3 |
Other filings by this issuer (1)
More